Market LIVE
Published markets; coverage varies by country
Product profile · United States

ZYKADIA

 ·  Patent Litigation & Settlement History ↓

IngredientCERITINIB
Application typeNDA
Application211225
Product001
Dosage formTABLET
RouteORAL
Strength150MG
Approval date2019-03-18
Marketing statusPrescription
Status event—
ApplicantNOVARTIS
Product source

Current GenericRadar decision

Year2030
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typePATENT
Anchor date2030-06-29
Patent anchor2030-06-29
Exclusivity anchor2024-05-26
Protection date—
First Final ANDA—
Status event—

POST_ANCHOR_RIGHTS_EXIST

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
78930742026-04-25DS/DP ————
———
83779212027-11-20U U-1179———
———
83994502027-11-20DS/DP ————
———
79645922028-04-29DS/DP ————
———
80394792030-06-29DS/DP ————
———
93092292032-01-18DS/DP ————
———
87037872032-02-02U U-1179———
———
123576302037-12-13U U-3096———
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE—2019-04-29FDA historical NCE 5-year new chemical entity exclusivity. Active-moiety-wide protection against covered follow-on NDA/ANDA applications; not indication-specific. Statutory exceptions or waivers are not excluded by this categorization.YY——Source
ODE*—2021-04-29Historical Orange Book exclusivity; scope and start date not independently established————Source
ODE*—2024-05-26Historical Orange Book exclusivity; scope and start date not independently established————Source

2026-10-10 · NO_RECORD_IN_CURRENT_SNAPSHOT · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (1)
TypeDateRoleBasisSource
REGULATORY_STATUS2030-06-29CANONICAL_DECISIONPOST_ANCHOR_RIGHTS_EXISTSource
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.